An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.

Saved in:
Bibliographic Details
Title: An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Authors: Xu Y; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Carrascosa LC; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Yeung YA; BMD, Pfizer Inc., San Diego, California., Chu ML; BMD, Pfizer Inc., San Diego, California., Yang W; Computational Biology, Pfizer Inc., San Diego, California., Djuretic I; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Pappas DC; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Zeytounian J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ge Z; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., de Ruiter V; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Starbeck-Miller GR; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Patterson J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Rigas D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Chen SH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kraynov E; BMD, Pfizer Inc., San Diego, California., Boor PP; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Noordam L; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Doukas M; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Tsao D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ijzermans JN; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Guo J; BMD, Pfizer Inc., San Diego, California., Grünhagen DJ; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Erdmann J; Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Verheij J; Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Royen ME; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.; Cancer Treatment Screening Facility (CTSF), Erasmus Medical Center, Rotterdam, the Netherlands., Doornebosch PG; Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands., Feldman R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Park T; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Mahmoudi S; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Dorywalska M; BMD, Pfizer Inc., San Diego, California., Ni I; BMD, Pfizer Inc., San Diego, California., Chin SM; BMD, Pfizer Inc., San Diego, California., Mistry T; BMD, Pfizer Inc., San Diego, California., Mosyak L; BMD, Pfizer Inc., San Diego, California., Lin L; BMD, Pfizer Inc., San Diego, California., Ching KA; Computational Biology, Pfizer Inc., San Diego, California., Lindquist KC; BMD, Pfizer Inc., San Diego, California., Ji C; DSRD, Pfizer Inc., San Diego, California., Londono LM; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kuang B; BMD, Pfizer Inc., San Diego, California., Rickert R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kwekkeboom J; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Sprengers D; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Huang TH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Chaparro-Riggers J; BMD, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.
Source: Cancer immunology research [Cancer Immunol Res] 2021 Oct; Vol. 9 (10), pp. 1141-1157. Date of Electronic Publication: 2021 Aug 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34376502
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Carrascosa+LC%22">Carrascosa LC</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Yeung+YA%22">Yeung YA</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chu+ML%22">Chu ML</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Computational Biology, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Djuretic+I%22">Djuretic I</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Pappas+DC%22">Pappas DC</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Zeytounian+J%22">Zeytounian J</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ge+Z%22">Ge Z</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Ruiter+V%22">de Ruiter V</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Starbeck-Miller+GR%22">Starbeck-Miller GR</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Patterson+J%22">Patterson J</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Rigas+D%22">Rigas D</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chen+SH%22">Chen SH</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kraynov+E%22">Kraynov E</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Boor+PP%22">Boor PP</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Noordam+L%22">Noordam L</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doukas+M%22">Doukas M</searchLink>; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tsao+D%22">Tsao D</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ijzermans+JN%22">Ijzermans JN</searchLink>; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guo+J%22">Guo J</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Grünhagen+DJ%22">Grünhagen DJ</searchLink>; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Erdmann+J%22">Erdmann J</searchLink>; Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Verheij+J%22">Verheij J</searchLink>; Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Royen+ME%22">van Royen ME</searchLink>; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.; Cancer Treatment Screening Facility (CTSF), Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doornebosch+PG%22">Doornebosch PG</searchLink>; Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Feldman+R%22">Feldman R</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Park+T%22">Park T</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mahmoudi+S%22">Mahmoudi S</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Dorywalska+M%22">Dorywalska M</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ni+I%22">Ni I</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chin+SM%22">Chin SM</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mistry+T%22">Mistry T</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mosyak+L%22">Mosyak L</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Computational Biology, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Lindquist+KC%22">Lindquist KC</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ji+C%22">Ji C</searchLink>; DSRD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Londono+LM%22">Londono LM</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kuang+B%22">Kuang B</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Rickert+R%22">Rickert R</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kwekkeboom+J%22">Kwekkeboom J</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sprengers+D%22">Sprengers D</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Huang+TH%22">Huang TH</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Chaparro-Riggers+J%22">Chaparro-Riggers J</searchLink>; BMD, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2021 Oct; Vol. 9 (10), pp. 1141-1157. <i>Date of Electronic Publication: </i>2021 Aug 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34376502
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-21-0058
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1141
    Titles:
      – TitleFull: An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Carrascosa LC
      – PersonEntity:
          Name:
            NameFull: Yeung YA
      – PersonEntity:
          Name:
            NameFull: Chu ML
      – PersonEntity:
          Name:
            NameFull: Yang W
      – PersonEntity:
          Name:
            NameFull: Djuretic I
      – PersonEntity:
          Name:
            NameFull: Pappas DC
      – PersonEntity:
          Name:
            NameFull: Zeytounian J
      – PersonEntity:
          Name:
            NameFull: Ge Z
      – PersonEntity:
          Name:
            NameFull: de Ruiter V
      – PersonEntity:
          Name:
            NameFull: Starbeck-Miller GR
      – PersonEntity:
          Name:
            NameFull: Patterson J
      – PersonEntity:
          Name:
            NameFull: Rigas D
      – PersonEntity:
          Name:
            NameFull: Chen SH
      – PersonEntity:
          Name:
            NameFull: Kraynov E
      – PersonEntity:
          Name:
            NameFull: Boor PP
      – PersonEntity:
          Name:
            NameFull: Noordam L
      – PersonEntity:
          Name:
            NameFull: Doukas M
      – PersonEntity:
          Name:
            NameFull: Tsao D
      – PersonEntity:
          Name:
            NameFull: Ijzermans JN
      – PersonEntity:
          Name:
            NameFull: Guo J
      – PersonEntity:
          Name:
            NameFull: Grünhagen DJ
      – PersonEntity:
          Name:
            NameFull: Erdmann J
      – PersonEntity:
          Name:
            NameFull: Verheij J
      – PersonEntity:
          Name:
            NameFull: van Royen ME
      – PersonEntity:
          Name:
            NameFull: Doornebosch PG
      – PersonEntity:
          Name:
            NameFull: Feldman R
      – PersonEntity:
          Name:
            NameFull: Park T
      – PersonEntity:
          Name:
            NameFull: Mahmoudi S
      – PersonEntity:
          Name:
            NameFull: Dorywalska M
      – PersonEntity:
          Name:
            NameFull: Ni I
      – PersonEntity:
          Name:
            NameFull: Chin SM
      – PersonEntity:
          Name:
            NameFull: Mistry T
      – PersonEntity:
          Name:
            NameFull: Mosyak L
      – PersonEntity:
          Name:
            NameFull: Lin L
      – PersonEntity:
          Name:
            NameFull: Ching KA
      – PersonEntity:
          Name:
            NameFull: Lindquist KC
      – PersonEntity:
          Name:
            NameFull: Ji C
      – PersonEntity:
          Name:
            NameFull: Londono LM
      – PersonEntity:
          Name:
            NameFull: Kuang B
      – PersonEntity:
          Name:
            NameFull: Rickert R
      – PersonEntity:
          Name:
            NameFull: Kwekkeboom J
      – PersonEntity:
          Name:
            NameFull: Sprengers D
      – PersonEntity:
          Name:
            NameFull: Huang TH
      – PersonEntity:
          Name:
            NameFull: Chaparro-Riggers J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2021 Oct
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1